会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Method of degrading transcriptional factors of saccharometabolism-associated gene, method for inhibiting the degradation, and agent for inhibiting degradation and degradation inhibitor
    • 降低糖代谢相关基因转录因子的方法,抑制降解的方法和抑制降解抑制剂
    • US20070004636A1
    • 2007-01-04
    • US10526234
    • 2003-08-29
    • Hirofumi DoiGen Kudo
    • Hirofumi DoiGen Kudo
    • C12Q1/37A61K38/05A61K38/04C07K5/06C07K5/04
    • C07K7/06A61K38/00C07K5/06043C07K5/06191C12N9/6472
    • Based on the finding that m-calpain or μ-calpain degrades hepatocyte nuclear factor 4α (HNF-4α), hepatocyte nuclear factor 1α (HNF-1α) and insulin promoter factor 1 (IPF-1), which form transcription factor networks involved in expression of glucose metabolism-related genes in pancreatic β cells, the following have been provided: a method for degradation of these transcription factors; a method for inhibiting the degradation and an agent for inhibiting the degradation; a method for enhancing production of the gene product of a gene on which these factors act as transcription factors and an agent for enhancing the same; an agent for preventing and/or treating a disease attributable to the degradation of these transcription factors and a method for preventing and/or treating the disease; a method for identifying a compound that inhibits the degradation of these transcription factors by calpain; a compound obtained by the identification method; and a reagent kit including calpain, these transcription factors, polynucleotides encoding these factors, and a vector containing the polynucleotides.
    • 基于m-calpain或mu-calpain降解肝细胞核因子4α(HNF-4alpha),肝细胞核因子1alpha(HNF-1alpha)和胰岛素启动子因子1(IPF-1)的发现,其形成转录因子网络 葡萄糖代谢相关基因在胰腺β细胞中的表达已经提供:一种降解这些转录因子的方法; 抑制降解的方法和抑制降解的试剂; 用于增强这些因子作为转录因子的基因的基因产物的产生的方法和用于增强其的药剂; 用于预防和/或治疗可归因于这些转录因子降解的疾病的药剂和预防和/或治疗疾病的方法; 用于鉴定通过钙蛋白酶抑制这些转录因子降解的化合物的方法; 通过鉴定方法获得的化合物; 以及包含钙蛋白酶,这些转录因子,编码这些因子的多核苷酸以及含有多核苷酸的载体的试剂盒。
    • 3. 发明申请
    • RNA IN SITU HYBRIDIZATION
    • RNA in SITU HYBRIDIZATION
    • US20110183331A1
    • 2011-07-28
    • US12993338
    • 2009-05-19
    • Hirofumi DoiMasahiro MatsuokaTatsuhiro NakanoChizuru Nagayoshi
    • Hirofumi DoiMasahiro MatsuokaTatsuhiro NakanoChizuru Nagayoshi
    • C12Q1/68
    • C12Q1/6832C12Q1/6841C12Q2543/10C12Q2527/125C12Q2545/101
    • Disclosed is a method for identifying the presence of a target gene mRNA, which comprises hybridizing one or more oligonucleic acid probes with the target gene mRNA expressed in a tissue sample, and detecting a low-molecular-weight compound label added to at least one of the bases of the oligonucleic acid probes, wherein the oligonucleic acid probes are contacted with the tissue sample for hybridization with the target gene mRNA after pretreating (prehybridizing) one or more dummy oligonucleic acids with the tissue sample, or a mixture of the oligonucleic acid probes and the dummy oligonucleic acids is contacted with the sample tissue to hybridize the oligonucleic acid probes with the target gene mRNA, and wherein the dummy oligonucleic acids are substantially equal in length with the oligonucleic acid probes, and are neither hybridizable with regions of the target gene mRNA with which the oligonucleic acid probes hybridize nor with the oligonucleic acid probes.
    • 公开了一种鉴定目标基因mRNA的存在的方法,其包括将一种或多种寡核酸探针与组织样品中表达的靶基因mRNA杂交,并检测添加到以下的至少一种的低分子量化合物标记: 寡核酸探针的碱基,其中寡聚核酸探针与组织样品接触,用于与组织样品预处理(预杂交)(预杂交)一种或多种假寡聚核酸或寡核酸探针的混合物与靶基因mRNA杂交 使虚拟寡核酸与样品组织接触,将寡核酸探针与靶基因mRNA杂交,并且其中虚拟寡核酸与寡核酸探针的长度基本相等,并且不与靶基因的区域杂交 寡聚核酸探针与其杂交的mRNA也不与低聚核酸探针杂交。
    • 4. 发明申请
    • ACTUATOR
    • 执行机构
    • US20100231070A1
    • 2010-09-16
    • US12305872
    • 2007-04-19
    • Kenta HatanoHirofumi DoiToshihiko Miyake
    • Kenta HatanoHirofumi DoiToshihiko Miyake
    • H02K7/06
    • H02K7/06
    • An actuator having an output axis which is moved linearly by a rotatory force, and a boss for holding the above-mentioned output axis in such a way that the output axis can move linearly includes a connecting member for propagating the linear motion of the above-mentioned output axis to an external device. The above-mentioned connecting member is comprised of a joint connected to the above-mentioned output axis, and a link plate having an end rotatably connected to the above-mentioned joint, and another end rotatably connected to the external device. A mechanism for preventing rotation of the above-mentioned output axis is constructed of only a connecting portion for connecting the above-mentioned joint, the above-mentioned link plate, and the above-mentioned external device to one another.
    • 具有通过旋转力线性移动的输出轴的致动器和用于保持上述输出轴线的凸起,使得输出轴线性线性地移动,具有用于传播上述输出轴的直线运动的连接部件, 提到的输出轴到外部设备。 上述连接构件包括连接到上述输出轴线的接头和具有可旋转地连接到上述接头的端部的连接板,以及可旋转地连接到外部设备的另一端。 用于防止上述输出轴的旋转的机构仅由用于将上述接头,上述连接板和上述外部装置彼此连接的连接部分构成。
    • 8. 发明授权
    • Device, method, and program storage medium for executing genetic algorithm
    • 用于执行遗传算法的设备,方法和程序存储介质
    • US06182057B2
    • 2001-01-30
    • US08990050
    • 1997-12-12
    • Yasuhiro KikuchiHirofumi Doi
    • Yasuhiro KikuchiHirofumi Doi
    • G06F1518
    • G06N3/126
    • A genetic algorithm executing device, in which search of a genetic algorithm is improved, sets a distribution of characters at each position of character strings represent candidates of solution, obtain the degree of disorder at each position by the distributions of characters, set a larger mutation rate at the position of which degree of disorder is higher. This device performs a mutation operation on the character strings according to the mutation rates. This device generates the new character strings by selecting positions of which degrees of disorder are higher than a predetermined value, and changing the character at the selected positions.
    • 遗传算法执行装置,其中改进了遗传算法的搜索,设置了字符串每个位置处的字符分布表示解的候选,通过字符分布获得每个位置的无序程度,设置较大的突变 在无序程度较高的位置的比率。 该装置根据突变率对字符串进行突变操作。 该装置通过选择无序程度高于预定值的位置并改变所选位置的字符来生成新的字符串。
    • 10. 发明申请
    • Remedy For Melanoma
    • 治疗黑色素瘤
    • US20070259805A1
    • 2007-11-08
    • US11658652
    • 2005-08-03
    • Hirofumi DoiSeiji SaitoKenji MurakamiYukako Kurita
    • Hirofumi DoiSeiji SaitoKenji MurakamiYukako Kurita
    • A61K38/00C12N5/06G01N33/53
    • G01N33/566
    • The present invention was aimed at reducing transcription activating activity of MITF-M to inhibit production of BCL2 gene product and thereby to allow treatment and/or prevention of melanoma The present invention provided a method of inhibiting production of BCL2 gene product and an agent for inhibiting the same, which inhibit binding of protein selected from a group consisting of HLF, ELK4 and CLOCK to MITF-M, a method of inducing cell death of melanoma cells, an agent for inducing the same, an agent for treating and/or preventing diseases accompanied by enhanced production of BCL2 gene product, such as melanoma, a method of treating and/or preventing the diseases, a method of identifying any one of the following compounds: a compound that inhibits the aforementioned binding; a compound that inhibits production of BCL2 gene product; and a compound that increases sensitivity of melanoma to melanoma drugs, as well as a reagent kit.
    • 本发明旨在降低MITF-M的转录激活活性以抑制BCL2基因产物的产生,从而能够治疗和/或预防黑素瘤本发明提供了抑制BCL2基因产物的生成和抑制作用的方法 相同的,其抑制了选自由HLF,ELK4和CLOCK组成的组的蛋白质与MITF-M的结合,诱导黑素瘤细胞的细胞死亡的方法,诱导它们的药剂,用于治疗和/或预防疾病的药剂 伴随着BCL2基因产物如黑素瘤的增强生产,治疗和/或预防疾病的方法,鉴定任何一种以下化合物的方法:抑制上述结合的化合物; 抑制BCL2基因产物生成的化合物; 以及增加黑素瘤对黑素瘤药物敏感性以及试剂盒的化合物。